14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $8.74 $12.25 Thursday, 2nd May 2024 PHAT stock ended at $9.76. This is 5.40% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 5.24% from a day low at $9.36 to a day high of $9.85.
90 days $6.07 $12.25
52 weeks $6.07 $17.00

Historical Phathom Pharmaceuticals, Inc. prices

Date Open High Low Close Volume
Dec 07, 2023 $8.33 $8.43 $8.02 $8.26 944 551
Dec 06, 2023 $9.01 $9.01 $8.38 $8.47 753 776
Dec 05, 2023 $8.50 $9.27 $8.11 $8.95 878 388
Dec 04, 2023 $7.35 $8.68 $7.35 $8.43 1 018 567
Dec 01, 2023 $6.99 $7.32 $6.91 $7.30 741 001
Nov 30, 2023 $7.20 $7.33 $6.96 $6.99 414 815
Nov 29, 2023 $7.24 $7.42 $7.06 $7.10 415 956
Nov 28, 2023 $7.25 $7.53 $6.87 $7.17 451 077
Nov 27, 2023 $7.39 $7.52 $7.08 $7.22 479 726
Nov 24, 2023 $7.06 $7.50 $6.99 $7.40 296 096
Nov 22, 2023 $7.24 $7.44 $6.95 $6.99 358 632
Nov 21, 2023 $7.40 $7.52 $7.13 $7.21 404 613
Nov 20, 2023 $7.24 $7.63 $7.24 $7.41 558 243
Nov 17, 2023 $7.28 $7.60 $7.26 $7.50 448 511
Nov 16, 2023 $7.34 $7.54 $7.17 $7.33 614 710
Nov 15, 2023 $7.14 $7.64 $7.09 $7.34 701 053
Nov 14, 2023 $7.41 $7.65 $7.02 $7.10 769 027
Nov 13, 2023 $7.45 $7.56 $7.11 $7.15 619 217
Nov 10, 2023 $7.88 $7.88 $6.83 $7.51 673 622
Nov 09, 2023 $8.38 $9.03 $7.82 $7.86 661 560
Nov 08, 2023 $8.12 $8.15 $7.68 $7.82 323 309
Nov 07, 2023 $7.97 $8.32 $7.69 $8.12 557 998
Nov 06, 2023 $8.35 $8.79 $7.77 $7.95 785 138
Nov 03, 2023 $8.08 $9.13 $8.08 $8.73 978 959
Nov 02, 2023 $9.93 $10.25 $7.76 $7.98 2 497 309
Click to get the best stock tips daily for free!

About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals. Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal re... PHAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT